<p>The Changes in Medication Prescribing Among the Older People with Cognitive Impairment in the Acute Care Setting</p>

Abstract

Purpose: Most older people with cognitive impairment usually have multiple comorbidities. In the last decade, the guidelines for the management of chronic diseases have been changed, leading to changes in the patterns of medication prescribing and in the prevalence of drugrelated problems (DRPs). The main objectives were to explore the changes in medication use and in the prevalence of polypharmacy (PP), the use of potentially inappropriate medications (PIMs) and drug-drug interactions (DDIs) among older hospitalized adults with cognitive impairment in a 5-year period. Patients and Methods: Older hospitalized patients with cognitive impairment diagnosed by cognitive performance scale (CPS) score of 2 or more at tertiary hospital in Brisbane, Australia in 2009 and 2015 to 2016 were enrolled. Prescribed medication use, and exposures to PP, PIM and/ or DDI were evaluated at two time points. The associated factors with patients exposed to >1 criteria of PP, PIM or DDI were analyzed by using logistic regression analyses. Results: The median number of prescribed medications was not significantly different between the two periods. The number of medications use as dermatological agents and analgesics substantially increased over 5 years. In contrast, there was a decrease in prescription of drugs for acid-related disorders, drugs used in diabetes, and mineral supplements. Most of the participants were exposed to at least one of PP, PIM or DDI. In multivariate regression analysis, the presence of diabetes diagnosis was a risk factor associated with increased exposure to >1 criteria of PP, PIM or DDI. Conclusion: The patterns of many prescribed medications use have altered in a 5-year period. The present study confirms that the majority of older adults with cognitive impairment admitted in an acute care setting are prone to PP, PIM and DDI. Comprehensive medication reviews should be undertaken in clinical care of older patients with cognitive impairment.

Associations between dietary and blood inflammatory indices and their effects on cognitive function in elderly Americans

“…The number of people living with dementia is increasing worldwide ( Afzal et al, 2014 ). The increasing incidence rates of cognitive impairment and dementia will lead to an increased incidence of various geriatric diseases, which will greatly increase medical investment and impose a heavy socioeconomic burden ( Mangialasche et al, 2009 ; Ruangritchankul et al, 2020 ). There is now evidence that cognitive impairment is related to human inflammation ( Ferrucci and Fabbri, 2018 ; Irwin and Vitiello, 2019 ; Barter et al, 2021 ; Minhas et al, 2021 ).…”

Joint effect of abnormal systemic immune-inflammation index (SII) levels and diabetes on cognitive function and survival rate: A population-based study from the NHANES 2011–2014

“…For example, in the United States, more than 6 million people over the age of 65 had been diagnosed with cognitive dysfunction by 2020, and that number is expected to increase to 13.85 million by 2060 [ 3 ]. The increase of cognitive impairment will lead to an increase in the incidence of various geriatric diseases, which will increase the investment of medical resources and cause a heavy socioeconomic burden [ 4 , 5 ]. Therefore, more effective prevention and control measures are urgently needed.…”

Association between the neutrophil-to-lymphocyte ratio and cognitive impairment: a meta-analysis of observational studies

“…Moreover, the presence of preoperative cognitive impairment is associated with a substantial increase in the risk of postoperative delirium, postoperative complications, 30-day readmission, discharge to assisted care, and 1-year mortality ( 15 ). Considering the aging population, cognitive impairment has emerged as a significant global public health concern ( 16 ). Therefore, there is an urgent clinical need to identify diagnostic biomarkers that can identify older adults who are susceptible to cognitive impairment.…”